BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan SH, Huang WC, Chang JW, Chang KJ, Kuo WH, Wang MY, Lin KY, Uen YH, Hou MF, Lin CM, Jang TH, Tu CW, Lee YR, Lee YH, Tien MT, Wang LH. MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis. Oncogene 2014;33:4496-507. [PMID: 24608434 DOI: 10.1038/onc.2014.10] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Huang C, Huang M, Chung H, Chiu S, Yadav P, Lin Y, Liu F, Matsuura I. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:3664-71. [DOI: 10.1016/j.bbadis.2018.08.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Okato A, Arai T, Yamada Y, Sugawara S, Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, Ichikawa T, Seki N. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma. Int J Mol Sci 2017;18:E1969. [PMID: 28902136 DOI: 10.3390/ijms18091969] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
3 Goicoechea I, Rezola R, Arestin M, M Caffarel M, Cortazar AR, Manterola L, Fernandez-Mercado M, Armesto M, Sole C, Larrea E, M Araujo A, Ancizar N, Plazaola A, Urruticoechea A, Carracedo A, Ruiz I, Alvarez Lopez I, H Lawrie C. Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases. F1000Res 2017;6:1606. [PMID: 29862012 DOI: 10.12688/f1000research.12393.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Ruan T, Lu S, Xu J, Zhou JY. lncRNA LINC00460 Functions as a Competing Endogenous RNA and Regulates Expression of BGN by Sponging miR-149-5p in Colorectal Cancer. Technol Cancer Res Treat 2021;20:1533033820964238. [PMID: 33472555 DOI: 10.1177/1533033820964238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Peng F, Xiong L, Tang H, Peng C, Chen J. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer. Tumor Biol 2016;37:14463-77. [DOI: 10.1007/s13277-016-5334-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
6 Nair MG, Somashekaraiah VM, Ramamurthy V, Prabhu JS, Sridhar TS. miRNAs: Critical mediators of breast cancer metastatic programming. Exp Cell Res 2021;401:112518. [PMID: 33607102 DOI: 10.1016/j.yexcr.2021.112518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chan SH, Wang LH. Regulation of cancer metastasis by microRNAs. J Biomed Sci. 2015;22:9. [PMID: 25614041 DOI: 10.1186/s12929-015-0113-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 11.9] [Reference Citation Analysis]
8 Zhao Z, Fan X, Jiang L, Xu Z, Xue L, Zhan Q, Song Y. miR-503-3p promotes epithelial–mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin. Journal of Genetics and Genomics 2017;44:75-84. [DOI: 10.1016/j.jgg.2016.10.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
9 Yoo SM, Cerione RA, Antonyak MA. The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression. Small GTPases 2020;11:77-85. [PMID: 28981399 DOI: 10.1080/21541248.2017.1362496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Hou J, Yan D, Liu Y, Huang P, Cui H. The Roles of Integrin α5β1 in Human Cancer. Onco Targets Ther 2020;13:13329-44. [PMID: 33408483 DOI: 10.2147/OTT.S273803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 He Y, Chen D, Yi Y, Zeng S, Liu S, Li P, Xie H, Yu P, Jiang G, Liu H. Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149. Mol Ther Oncolytics 2020;17:448-59. [PMID: 32478168 DOI: 10.1016/j.omto.2020.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Baumann V, Winkler J. miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem. 2014;6:1967-1984. [PMID: 25495987 DOI: 10.4155/fmc.14.116] [Cited by in Crossref: 120] [Cited by in F6Publishing: 118] [Article Influence: 17.1] [Reference Citation Analysis]
13 Fisher JN, Terao M, Fratelli M, Kurosaki M, Paroni G, Zanetti A, Gianni M, Bolis M, Lupi M, Tsykin A, Goodall GJ, Garattini E. MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells. Oncotarget 2015;6:13176-200. [PMID: 25961594 DOI: 10.18632/oncotarget.3759] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
14 Connor K, Murray DW, Jarzabek MA, Tran NL, White K, Dicker P, Sweeney KJ, O'Halloran PJ, MacCarthy B, Shiels LP, Lodi F, Lambrechts D, Sarkaria JN, Schiffelers RM, Symons M, Byrne AT. Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies. Cancers (Basel) 2020;12:E3531. [PMID: 33256106 DOI: 10.3390/cancers12123531] [Reference Citation Analysis]
15 Zhou C, Wang P, Tu M, Huang Y, Xiong F, Wu Y. Long Non-Coding RNA PART1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells via miR-149-5p/MAP2K1 Axis. Cancer Manag Res 2020;12:3771-82. [PMID: 32547213 DOI: 10.2147/CMAR.S246311] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Shi X, Wang X, Hua Y. LncRNA GACAT1 Promotes Gastric Cancer Cell Growth, Invasion And Migration By Regulating MiR-149-mediated Of ZBTB2 And SP1. J Cancer 2018;9:3715-22. [PMID: 30405842 DOI: 10.7150/jca.27546] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
17 Huang L, Li B, He C, Zhao Y, Yang X, Pang B, Zhang X, Shan Y. Sulforaphane inhibits human bladder cancer cell invasion by reversing epithelial-to-mesenchymal transition via directly targeting microRNA-200c/ZEB1 axis. Journal of Functional Foods 2018;41:118-26. [DOI: 10.1016/j.jff.2017.12.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Tao WY, Wang CY, Sun YH, Su YH, Pang D, Zhang GQ. MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1. J Cancer 2016;7:1653-62. [PMID: 27698902 DOI: 10.7150/jca.14762] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
19 Zhi Y, Zhou H, Mubalake A, Chen Y, Zhang B, Zhang K, Chu X, Wang R. Regulation and functions of MicroRNA-149 in human cancers. Cell Prolif 2018;51:e12465. [PMID: 29999552 DOI: 10.1111/cpr.12465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
20 Xie RT, Cong XL, Zhong XM, Luo P, Yang HQ, Lu GX, Luo P, Chang ZY, Sun R, Wu TM, Lv ZW, Fu D, Ma YS. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 2018;15:4571-7. [PMID: 29541227 DOI: 10.3892/ol.2018.7892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
21 Zhan Y, Xiang F, Wu R, Xu J, Ni Z, Jiang J, Kang X. MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88. J Ovarian Res 2015;8:48. [PMID: 26223974 DOI: 10.1186/s13048-015-0178-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
22 Ye X, Chen X. miR-149-5p inhibits cell proliferation and invasion through targeting GIT1 in medullary thyroid carcinoma. Oncol Lett. 2019;17:372-378. [PMID: 30655777 DOI: 10.3892/ol.2018.9628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Fang Y, Zhu X, Wang J, Li N, Li D, Sakib N, Sha Z, Song W. MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5. Oncotarget 2015;6:13164-75. [PMID: 25961434 DOI: 10.18632/oncotarget.3754] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tassinari M, Richter SN, Gandellini P. Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome. Nucleic Acids Res 2021;49:3617-33. [PMID: 33721024 DOI: 10.1093/nar/gkab127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer 2019;18:42. [PMID: 30885232 DOI: 10.1186/s12943-019-0988-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 81] [Article Influence: 24.0] [Reference Citation Analysis]
26 Tu XM, Gu YL, Ren GQ. miR-125a-3p targetedly regulates GIT1 expression to inhibit osteoblastic proliferation and differentiation. Exp Ther Med 2016;12:4099-106. [PMID: 28101188 DOI: 10.3892/etm.2016.3874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
27 Lu X, Wan F, Zhang H, Shi G, Ye D. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Tumour Biol 2016;37:253-62. [PMID: 26198048 DOI: 10.1007/s13277-015-3792-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
28 Gao Y, Guo X, Li Y, Sha W, She R. The decreased lncRNA ZEB2-AS1 in pre-eclampsia controls the trophoblastic cell line HTR-8/SVneo's invasive and migratory abilities via the miR-149/PGF axis. J Cell Biochem 2019;120:17677-86. [PMID: 31148230 DOI: 10.1002/jcb.29034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 He Y, Yu D, Zhu L, Zhong S, Zhao J, Tang J. miR-149 in Human Cancer: A Systemic Review. J Cancer 2018;9:375-88. [PMID: 29344284 DOI: 10.7150/jca.21044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
30 Weidle UH, Dickopf S, Hintermair C, Kollmorgen G, Birzele F, Brinkmann U. The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets. Cancer Genomics Proteomics 2018;15:17-39. [PMID: 29275360 DOI: 10.21873/cgp.20062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
31 Lu CX, Wu XL, Zhang GY, Gu XT, Ma X, He DX. Interplay between regulation by methylation and noncoding RNAs in cancers. Eur J Cancer Prev 2018;27:418-24. [PMID: 29557800 DOI: 10.1097/CEJ.0000000000000433] [Reference Citation Analysis]
32 Jeong SJ, Lee KH, Nam AR, Cho JY. Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer. Cancers (Basel) 2019;11:E1466. [PMID: 31569550 DOI: 10.3390/cancers11101466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Dong Y, Chang C, Liu J, Qiang J. Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo. Onco Targets Ther. 2017;10:5873-5882. [PMID: 29270025 DOI: 10.2147/ott.s144280] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
34 Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Mol Cancer. 2014;13:253. [PMID: 25424347 DOI: 10.1186/1476-4598-13-253] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
35 Kwok CK, Sahakyan AB, Balasubramanian S. Structural Analysis using SHALiPE to Reveal RNA G-Quadruplex Formation in Human Precursor MicroRNA. Angew Chem Int Ed Engl 2016;55:8958-61. [PMID: 27355429 DOI: 10.1002/anie.201603562] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 8.8] [Reference Citation Analysis]
36 Jiang Q, He M, Guan S, Ma M, Wu H, Yu Z, Jiang L, Wang Y, Zong X, Jin F, Wei M. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway. Tumour Biol 2016;37:5001-11. [PMID: 26537584 DOI: 10.1007/s13277-015-4342-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
37 Ma Z, Han C, Xia W, Wang S, Li X, Fang P, Yin R, Xu L, Yang L. circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS. Cell Death Dis 2020;11:356. [PMID: 32393760 DOI: 10.1038/s41419-020-2514-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
38 Chang JW, Kuo WH, Lin CM, Chen WL, Chan SH, Chiu MF, Chang IS, Jiang SS, Tsai FY, Chen CH, Huang PH, Chang KJ, Lin KT, Lin SC, Wang MY, Uen YH, Tu CW, Hou MF, Tsai SF, Shen CY, Tung SL, Wang LH. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway. Oncogene 2018;37:4137-50. [PMID: 29706651 DOI: 10.1038/s41388-018-0253-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
39 Chen D, Li Y, Wang L, Jiao K. SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma. Int J Breast Cancer 2015;2015:539721. [PMID: 25973277 DOI: 10.1155/2015/539721] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
40 Li J, Wang Q, Wen R, Liang J, Zhong X, Yang W, Su D, Tang J. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C. J Cell Mol Med 2015;19:2793-805. [PMID: 26283050 DOI: 10.1111/jcmm.12666] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
41 Zhou Q, Zeng H, Ye P, Shi Y, Guo J, Long X. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells. Anticancer Drugs 2018;29:539-48. [PMID: 29557813 DOI: 10.1097/CAD.0000000000000623] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
42 Grzywa TM, Klicka K, Włodarski PK. Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis. Cancers (Basel) 2020;12:E3709. [PMID: 33321819 DOI: 10.3390/cancers12123709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
43 Chen T, Wang X, Li C, Zhang H, Liu Y, Han D, Li Y, Li Z, Luo D, Zhang N, Zheng M, Chen B, Wang L, Zhao W, Yang Q. CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation. Oncogene 2021;40:2756-71. [PMID: 33714984 DOI: 10.1038/s41388-021-01739-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zhang J, Zhang J, Liu W, Ge R, Gao T, Tian Q, Mu X, Zhao L, Li X. UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription. Cancer Cell Int 2021;21:543. [PMID: 34663332 DOI: 10.1186/s12935-021-02237-8] [Reference Citation Analysis]
45 Casalou C, Ferreira A, Barral DC. The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective. Front Cell Dev Biol 2020;8:217. [PMID: 32426352 DOI: 10.3389/fcell.2020.00217] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
46 Yan Y, Wang R, Guan W, Qiao M, Wang L. Roles of microRNAs in cancer associated fibroblasts of gastric cancer. Pathol Res Pract 2017;213:730-6. [PMID: 28554761 DOI: 10.1016/j.prp.2017.02.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
47 Zhu X, Liu Y, Jing R, Huang Y, Guo J, Lin Y, Liang Y, Li Y, Li M. Network characteristics of human RNA-RNA interactions and application in the discovery of breast cancer-associated RNAs. Chemometrics and Intelligent Laboratory Systems 2020;206:104164. [DOI: 10.1016/j.chemolab.2020.104164] [Reference Citation Analysis]
48 Zhou Z, Zhang S, Xiong Y. Long noncoding RNA MIAT promotes non-small cell lung cancer progression by sponging miR-149-5p and regulating FOXM1 expression. Cancer Cell Int 2020;20:348. [PMID: 32742195 DOI: 10.1186/s12935-020-01432-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 Liu HT, Ma RR, Lv BB, Zhang H, Shi DB, Guo XY, Zhang GH, Gao P. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer. Br J Cancer 2020;122:1825-36. [PMID: 32336754 DOI: 10.1038/s41416-020-0836-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
50 Fu D, Ji Q, Wang C, Yu L, Yu R. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis. Cell Cycle 2021;:1-18. [PMID: 34720052 DOI: 10.1080/15384101.2021.1988227] [Reference Citation Analysis]
51 Fang C, Li XP, Chen YX, Wu NY, Yin JY, Zhang W, Zhou HH, Liu ZQ. Functional miRNA variants affect lung cancer susceptibility and platinum-based chemotherapy response. J Thorac Dis 2018;10:3329-40. [PMID: 30069329 DOI: 10.21037/jtd.2018.05.145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
52 Yamauchi Y, Miura Y, Kanaho Y. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs. Adv Biol Regul 2017;63:115-21. [PMID: 27776975 DOI: 10.1016/j.jbior.2016.10.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
53 Qian B, Zhao L, Wang X, Xu J, Teng F, Gao L, Shen R. RETRACTED: miR-149 regulates the proliferation and apoptosis of cervical cancer cells by targeting GIT1. Biomedicine & Pharmacotherapy 2018;105:1106-16. [DOI: 10.1016/j.biopha.2018.06.075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
54 Zhang Q, Yu L, Qin D, Huang R, Jiang X, Zou C, Tang Q, Chen Y, Wang G, Wang X, Gao X. Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One 2015;10:e0120698. [PMID: 25799050 DOI: 10.1371/journal.pone.0120698] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
55 Lin L, Zhang YD, Chen ZY, Chen Y, Ren CP. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy. Tumour Biol 2016;37:12339-46. [PMID: 27300349 DOI: 10.1007/s13277-016-5106-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
56 Chen J, Chen J, Li W. MicroRNA-149 targets specificity protein 1 to suppress human tongue squamous cell carcinoma cell proliferation and motility. Oncol Lett 2017;13:851-6. [PMID: 28356969 DOI: 10.3892/ol.2016.5527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Saldanha SN, Royston KJ, Udayakumar N, Tollefsbol TO. Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing. Int J Mol Sci 2015;17:E16. [PMID: 26712738 DOI: 10.3390/ijms17010016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
58 Zhao LY, Tong DD, Xue M, Ma HL, Liu SY, Yang J, Liu YX, Guo B, Ni L, Liu LY, Qin YN, Wang LM, Zhao XG, Huang C. MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1. Oncogenesis. 2017;6:e368. [PMID: 28759023 DOI: 10.1038/oncsis.2017.60] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
59 Zhou W, Li X, Premont RT. Expanding functions of GIT Arf GTPase-activating proteins, PIX Rho guanine nucleotide exchange factors and GIT-PIX complexes. J Cell Sci 2016;129:1963-74. [PMID: 27182061 DOI: 10.1242/jcs.179465] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
60 Yoo SM, Latifkar A, Cerione RA, Antonyak MA. Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation. J Biol Chem 2017;292:3947-57. [PMID: 28100775 DOI: 10.1074/jbc.M116.769190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Abdalla F, Singh B, Bhat HK. MicroRNAs and gene regulation in breast cancer. J Biochem Mol Toxicol 2020;34. [DOI: 10.1002/jbt.22567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
62 Chang JS, Su CY, Yu WH, Lee WJ, Liu YP, Lai TC, Jan YH, Yang YF, Shen CN, Shew JY, Lu J, Yang CJ, Huang MS, Lu PJ, Lin YF, Kuo ML, Hua KT, Hsiao M. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis. Oncotarget. 2015;6:36278-36291. [PMID: 26462147 DOI: 10.18632/oncotarget.5531] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
63 Xu M, Xiao J, Chen M, Yuan L, Li J, Shen H, Yao S. miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway. Int J Oncol 2018;52:815-27. [PMID: 29393390 DOI: 10.3892/ijo.2018.4252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
64 Klinge CM. miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol 2015;418 Pt 3:273-97. [PMID: 25659536 DOI: 10.1016/j.mce.2015.01.035] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 9.9] [Reference Citation Analysis]
65 Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Oncotarget 2015;6:37808-23. [PMID: 26498692 DOI: 10.18632/oncotarget.5676] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 6.5] [Reference Citation Analysis]
66 Bellazzo A, Di Minin G, Valentino E, Sicari D, Torre D, Marchionni L, Serpi F, Stadler MB, Taverna D, Zuccolotto G, Montagner IM, Rosato A, Tonon F, Zennaro C, Agostinis C, Bulla R, Mano M, Del Sal G, Collavin L. Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells. Cell Death Differ 2018;25:1224-38. [PMID: 29568059 DOI: 10.1038/s41418-018-0088-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
67 Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv G, Zou Z, Jiang XC, Zou C, Liu W, Luo J, Zhao Z, Muhammad S, Wang G, Chen YG, Wang X. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol Cell Biol 2015;35:988-1000. [PMID: 25582198 DOI: 10.1128/MCB.01242-14] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
68 Chen J, Yang P, Yang J, Wen Z, Zhang B, Zheng X. GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma. Onco Targets Ther 2015;8:3731-42. [PMID: 26719701 DOI: 10.2147/OTT.S96715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
69 Fogli S, Polini B, Carpi S, Pardini B, Naccarati A, Dubbini N, Lanza M, Breschi MC, Romanini A, Nieri P. Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. Tumour Biol 2017;39:1010428317701646. [PMID: 28466785 DOI: 10.1177/1010428317701646] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
70 Yang Y, Wei L, Zhang Y, Hayano T, Piñeiro Pereda MDP, Nakaoka H, Li Q, Barragán Mallofret I, Lu Y, Tamagnone L, Inoue I, Li X, Luo J, Zheng K, You H. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis. Clin Exp Metastasis 2018;35:109-21. [DOI: 10.1007/s10585-018-9901-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
71 Tsai HP, Huang SF, Li CF, Chien HT, Chen SC. Differential microRNA expression in breast cancer with different onset age. PLoS One 2018;13:e0191195. [PMID: 29324832 DOI: 10.1371/journal.pone.0191195] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
72 Casalou C, Faustino A, Barral DC. Arf proteins in cancer cell migration. Small GTPases 2016;7:270-82. [PMID: 27589148 DOI: 10.1080/21541248.2016.1228792] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
73 He DX, Gu XT, Li YR, Jiang L, Jin J, Ma X. Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer. FEBS J. 2014;281:4718-4730. [PMID: 25156775 DOI: 10.1111/febs.13012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
74 Nam SH, Kanwal S, Nam DE, Lee MH, Kang TH, Jung SC, Choi BO, Chung KW. Association of miR-149 polymorphism with onset age and severity in Charcot-Marie-Tooth disease type 1A. Neuromuscul Disord 2018;28:502-7. [PMID: 29729827 DOI: 10.1016/j.nmd.2018.04.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
75 Giguère H, Dumont AA, Berthiaume J, Oliveira V, Laberge G, Auger-Messier M. ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression. Sci Rep 2018;8:13605. [PMID: 30206251 DOI: 10.1038/s41598-018-31784-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
76 Yang S, Chen J, Lv B, Zhang J, Li D, Huang M, Yuan L, Yin G. Decreased long non-coding RNA lincFOXF1 indicates poor progression and promotes cell migration and metastasis in osteosarcoma. J Cell Mol Med 2020;24:12633-41. [PMID: 32945076 DOI: 10.1111/jcmm.15828] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Tsai KW, Chong KH, Li CH, Tu YT, Chen YR, Lee MC, Chan SH, Wang LH, Chang YJ. LOC550643, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis. Front Cell Dev Biol 2021;9:695632. [PMID: 34354991 DOI: 10.3389/fcell.2021.695632] [Reference Citation Analysis]
78 Chang CC, Chiu CC, Liu PF, Wu CH, Tseng YC, Lee CH, Shu CW. Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells. Cancers (Basel) 2021;13:5779. [PMID: 34830933 DOI: 10.3390/cancers13225779] [Reference Citation Analysis]
79 Qiao EQ, Yang HJ, Zhang XP. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis. J Zhejiang Univ Sci B 2020;21:495-508. [PMID: 32478495 DOI: 10.1631/jzus.B1900584] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Chen J, Ge L, Liu A, Yuan Y, Ye J, Zhong J, Liu L, Chen X. Identification of pathways related to FAF1/H. pylori-associated gastric carcinogenesis through an integrated approach based on iTRAQ quantification and literature review. Journal of Proteomics 2016;131:163-76. [DOI: 10.1016/j.jprot.2015.10.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
81 Sui X, Wang X, Han W, Li D, Xu Y, Lou F, Zhou J, Gu X, Zhu J, Zhang C, Pan H. MicroRNAs-mediated cell fate in triple negative breast cancers. Cancer Lett 2015;361:8-12. [PMID: 25748387 DOI: 10.1016/j.canlet.2015.02.048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
82 Cao D, Jia Z, You L, Wu Y, Hou Z, Suo Y, Zhang H, Wen S, Tsukamoto T, Oshima M, Jiang J, Cao X. 18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling. Oncotarget 2016;7:71960-73. [PMID: 27713126 DOI: 10.18632/oncotarget.12443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
83 Ge L, Wang Y, Duan QH, Liu SS, Liu GJ. MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription. World J Gastroenterol 2019; 25(45): 6619-6633 [PMID: 31832002 DOI: 10.3748/wjg.v25.i45.6619] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
84 Ghosh A, Ekka MK, Tawani A, Kumar A, Chakraborty D, Maiti S. Restoration of miRNA-149 Expression by TmPyP4 Induced Unfolding of Quadruplex within Its Precursor. Biochemistry 2019;58:514-25. [PMID: 30585723 DOI: 10.1021/acs.biochem.8b00880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
85 Majumder S, Zhu G, Xu X, Senchanthisai S, Jiang D, Liu H, Xue C, Wang X, Coia H, Cui Z, Smolock EM, Libby RT, Berk BC, Pang J. G-Protein-Coupled Receptor-2-Interacting Protein-1 Controls Stalk Cell Fate by Inhibiting Delta-like 4-Notch1 Signaling. Cell Rep 2016;17:2532-41. [PMID: 27926858 DOI: 10.1016/j.celrep.2016.11.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
86 Kwok CK, Sahakyan AB, Balasubramanian S. Structural Analysis using SHALiPE to Reveal RNA G-Quadruplex Formation in Human Precursor MicroRNA. Angew Chem 2016;128:9104-7. [DOI: 10.1002/ange.201603562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
87 Abdul-Maksoud RS, Elsayed RS, Elsayed WSH, Sediq AM, Rashad NM, Shaker SE, Ahmed SM. Combined serum miR-29c and miR-149 expression analysis as diagnostic genetic markers for colorectal cancer. Biotechnol Appl Biochem 2021;68:732-43. [PMID: 32678466 DOI: 10.1002/bab.1986] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Li H, Cui Z, Lv X, Li J, Gao M, Yang Z, Bi Y, Zhang Z, Wang S, Li S, Zhou B, Yin Z. Long Non-coding RNA HOTAIR Function as a Competing Endogenous RNA for miR-149-5p to Promote the Cell Growth, Migration, and Invasion in Non-small Cell Lung Cancer. Front Oncol 2020;10:528520. [PMID: 33102210 DOI: 10.3389/fonc.2020.528520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
89 Sha HH, Wang DD, Chen D, Liu SW, Wang Z, Yan DL, Dong SC, Feng JF. MiR-138: A promising therapeutic target for cancer. Tumour Biol 2017;39:1010428317697575. [PMID: 28378633 DOI: 10.1177/1010428317697575] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
90 Wang YH, Shen CY, Lin SC, Kuo WH, Kuo YT, Hsu YL, Wang WC, Lin KT, Wang LH. Monocytes secrete CXCL7 to promote breast cancer progression. Cell Death Dis 2021;12:1090. [PMID: 34789744 DOI: 10.1038/s41419-021-04231-4] [Reference Citation Analysis]
91 Xu RD, Feng F, Yu XS, Liu ZD, Lao LF. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma. Int J Immunopathol Pharmacol 2018;32:2058738418786656. [PMID: 30014744 DOI: 10.1177/2058738418786656] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]